29710-25-6 Usage
General Description
2-ethylhexyl 12-hydroxyoctadecanoate, also known as octyl hydroxystearate, is a chemical compound commonly used in cosmetics and personal care products as an emollient and skin conditioning agent. Its main function is to provide a smooth and silky texture to the skin, making it a popular ingredient in lotions, creams, and sunscreen formulations. 2-ethylhexyl 12-hydroxyoctadecanoate is derived from fatty acids and is considered safe for use in cosmetics, as it has low potential for skin irritation and sensitivity. It is also used as a lubricant in industrial applications and as a plasticizer in the production of plastics and rubbers. Overall, 2-ethylhexyl 12-hydroxyoctadecanoate is a versatile compound with various applications in both personal care and industrial settings.
Check Digit Verification of cas no
The CAS Registry Mumber 29710-25-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,7,1 and 0 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 29710-25:
(7*2)+(6*9)+(5*7)+(4*1)+(3*0)+(2*2)+(1*5)=116
116 % 10 = 6
So 29710-25-6 is a valid CAS Registry Number.
InChI:InChI=1/C26H52O3/c1-4-7-9-16-20-25(27)21-17-14-12-10-11-13-15-18-22-26(28)29-23-24(6-3)19-8-5-2/h24-25,27H,4-23H2,1-3H3
29710-25-6Relevant articles and documents
Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
-
, (2008/06/13)
The invention concerns a pharmaceutical composition for transdermal administration comprising: a polymeric release matrix capable of forming a soft film after drying, selected among cellulose polymers or copolymers, said matrix being present at a concentration not exceeding 6% of the composition weight; an active principle selected among the group of non-steroid anti-inflammatory agents comprising at least a metal carboxylic or carboxitate group; a transcutaneous absorption promoter of the active principle; water; and at least a physiologically acceptable non-aqueous solvent capable of dissolving the release matrix, the active principle and transcutaneous absorption promoter and to be rapidly eliminated by evaporation in contact with the skin.
